Cancers, Vol. 16, Pages 1262: Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder

This study was the first of this kind and could motivate the use of the “transthyretin binder concept” for the development of future radiopharmaceuticals.

Source: Cancers - March 23, 2024 Category: Cancer & Oncology Authors: Christian Vaccarin Ana Katrina Mapanao Luisa M. Deberle Anna E. Becker Francesca Borgna Giovanni Marzaro Roger Schibli Cristina M üller Tags: Article Source Type: research